EUVIMEDEUVIMED entdecken
Multizentrische Studie

Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study

Adnan Batman iD, Dilek Yazıcı iD, Oğuz Dikbaş, Kemal Ağbaht iD, Emre Sedar Saygılı iD, İbrahim Demirci iD, Nurbanu Bursa iD, Görkem Ayas iD, Cüneyd Anıl iD, Mustafa Cesur iD, Fatma Nur Korkmaz iD, Adile Begüm Bahçecioglu iD und 48 weitere

The Journal of Clinical Endocrinology & Metabolism · 18.09.2023 · 108 (10) · e1013-e1026

DOI: 10.1210/clinem/dgad235 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 25.04.2023. Verfasst von Adnan Batman und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology and Metabolism, School of Medicine, Koc University, 34010 Istanbul, Turkey. Hauptthemen laut MEDLINE: Thyroiditis, Subacute, COVID-19, Hypothyroidism. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The aims of the study are to compare characteristics of subacute thyroiditis (SAT) related to different etiologies, and to identify predictors of recurrence of SAT and incident hypothyroidism.

Methods

This nationwide, multicenter, retrospective cohort study included 53 endocrinology centers in Turkey. The study participants were divided into either COVID-19–related SAT (Cov-SAT), SARS-CoV-2 vaccine–related SAT (Vac-SAT), or control SAT (Cont-SAT) groups.

Results

Of the 811 patients, 258 (31.8%) were included in the Vac-SAT group, 98 (12.1%) in the Cov-SAT group, and 455 (56.1%) in the Cont-SAT group. No difference was found between the groups with regard to laboratory and imaging findings. SAT etiology was not an independent predictor of recurrence or hypothyroidism. In the entire cohort, steroid therapy requirement and younger age were statistically significant predictors for SAT recurrence. C-reactive protein measured during SAT onset, female sex, absence of antithyroid peroxidase (TPO) positivity, and absence of steroid therapy were statistically significant predictors of incident (early) hypothyroidism, irrespective of SAT etiology. On the other hand, probable predictors of established hypothyroidism differed from that of incident hypothyroidism.

Conclusion

Since there is no difference in terms of follow-up parameters and outcomes, COVID-19– and SARS-CoV-2 vaccine–related SAT can be treated and followed up like classic SATs. Recurrence was determined by younger age and steroid therapy requirement. Steroid therapy independently predicts incident hypothyroidism that may sometimes be transient in overall SAT and is also associated with a lower risk of established hypothyroidism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroiditis, SubacuteCOVID-19HypothyroidismHumansFemaleCOVID-19 VaccinesRetrospective StudiesSARS-CoV-2Steroids

Stichwörter der Autor:innen

COVID-19SARS-CoV-2 vaccinesubacute thyroiditis

Substanzen

COVID-19 VaccinesSteroids

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Endocrinology and Metabolism, School of Medicine, Koc University, 34010 Istanbul, Turkey.
  • Department of Endocrinology and Metabolism, Giresun University School of Medicine, 28200 Giresun, Turkey.
  • Department of Endocrinology and Metabolism, Defne Hospital, 31030 Hatay, Turkey.
  • Department of Internal Medicine, Division of Endocrinology and Metabolism, Faculty of Medicine, Canakkale Onsekiz Mart University, 17020 Canakkale, Turkey.
  • Department of Endocrinology and Metabolism, Gulhane Training and Research Hospital, University of Health Sciences Turkey, 06010 Ankara, Turkey.
  • Department of Statistics Beytepe, Hacettepe University, 06230 Ankara, Turkey.

ORCID-Profile: Adnan Batman, Dilek Yazıcı, Kemal Ağbaht, Emre Sedar Saygılı, İbrahim Demirci, Nurbanu Bursa, Görkem Ayas, Cüneyd Anıl, Mustafa Cesur, Fatma Nur Korkmaz, Adile Begüm Bahçecioglu, Demet Çorapçıoğlu, Murat Faik Erdoğan, Hayri Bostan, Murat Calapkulu, Sema Hepşen, Bekir Uçan, Erman Çakal, Bağdagül Yüksel Güler, Cem Haymana, Süleyman Hilmi İpekçi, Selami Aydın, Havva Sezer, Seçil Özışık, Oğuzhan Deyneli, Faruk Alagöl, Refik Tanakol, Mustafa Eroğlu, Ümmü Mutlu, Hülya Hacışahinoğulları, Ayşe Kubat Üzüm, Canan Demir, Gönül Koç, Sevde Nur Fırat, Tülay Omma, Şefika Burçak Polat, Cevdet Aydın, Bekir Çakır, Çiğdem Tura Bahadır, Mehmet Güven, Mehmet Sözen, Alev Selek, Zeynep Cantürk, Berrin Çetinarslan, Mustafa Aydemir, Işılay Taşkaldıran, Yusuf Bozkuş, Özlem Turhan İyidir, Seda Erem Basmaz, Mehmet Çağrı Ünal, Tevfik Demir, Ayten Oğuz, Özlem Çelik, Merve Yilmaz, Aykut Cimsir, Serdar Kayıhan

Zitieren

APA

Batman, A., Yazıcı, D., Dikbaş, O., Ağbaht, K., Saygılı, E. S., Demirci, İ., Bursa, N., Ayas, G., Anıl, C., Cesur, M., Korkmaz, F. N., Bahçecioglu, A. B., Çorapçıoğlu, D., Erdoğan, M. F., Bostan, H., Calapkulu, M., Hepşen, S., Uçan, B., Çakal, E., …, & Kayıhan, S. (2023). Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study. The Journal of Clinical Endocrinology & Metabolism, 108(10), e1013-e1026. https://doi.org/10.1210/clinem/dgad235

Vancouver

Batman A, Yazıcı D, Dikbaş O, Ağbaht K, Saygılı ES, Demirci İ, et al. Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study. The Journal of Clinical Endocrinology & Metabolism. 2023;108(10):e1013-e1026. doi:10.1210/clinem/dgad235

BibTeX
@article{Batman2023,
  author = {Batman, Adnan and Yazıcı, Dilek and Dikbaş, Oğuz and Ağbaht, Kemal and Saygılı, Emre Sedar and Demirci, İbrahim and Bursa, Nurbanu and Ayas, Görkem and Anıl, Cüneyd and Cesur, Mustafa and Korkmaz, Fatma Nur and Bahçecioglu, Adile Begüm and Çorapçıoğlu, Demet and Erdoğan, Murat Faik and Bostan, Hayri and Calapkulu, Murat and Hepşen, Sema and Uçan, Bekir and Çakal, Erman and Güler, Bağdagül Yüksel and Haymana, Cem and İpekçi, Süleyman Hilmi and Aydın, Selami and Sezer, Havva and Özışık, Seçil and Deyneli, Oğuzhan and Alagöl, Faruk and Tanakol, Refik and Eroğlu, Mustafa and Mutlu, Ümmü and Hacışahinoğulları, Hülya and Üzüm, Ayşe Kubat and Demir, Canan and Koç, Gönül and Fırat, Sevde Nur and Omma, Tülay and İnce, Nurcan and Polat, Şefika Burçak and Topaloğlu, Oya and Aydın, Cevdet and Çakır, Bekir and Bahadır, Çiğdem Tura and Güven, Mehmet and Sözen, Mehmet and Selek, Alev and Cantürk, Zeynep and Çetinarslan, Berrin and Aydemir, Mustafa and Taşkaldıran, Işılay and Bozkuş, Yusuf and İyidir, Özlem Turhan and Haydardedeoğlu, Filiz Ekşi and Basmaz, Seda Erem and Ünal, Mehmet Çağrı and Demir, Tevfik and Oğuz, Ayten and Çelik, Özlem and Yilmaz, Merve and Cimsir, Aykut and Kayıhan, Serdar},
  title = {Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  volume = {108},
  number = {10},
  pages = {e1013--e1026},
  doi = {10.1210/clinem/dgad235}
}
Kostenlos starten →